-
Mashup Score: 2EASD2022 Interview with The 2022 EASD Albert Renold Prize Lecture awardee Maike Sander - 1 year(s) ago
#easd2022 #diabetes #betacells #stemcells
Source: YouTubeCategories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 3New Studies Change Beliefs About Cardiovascular Disease - 1 year(s) ago
From timing of medications to supplement use, Dr Anne Peters reviews several recent studies that have changed beliefs in the realm of cardiovascular disease.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
From timing of medications to supplement use, Dr Anne Peters reviews several recent studies that have changed beliefs in the realm of cardiovascular disease. https://t.co/8fvC6Grdvr #EASD2022 https://t.co/Li5CmjSt7c
-
-
Mashup Score: 3Lab-Grown Muscle Sucks Up Sugar to Fight Diabetes - 2 year(s) ago
Scientists from Israel have found a way to genetically engineer human muscle so it absorbs a lot more glucose. It may help treat type 2 diabetes someday.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
A genetically engineered human muscle absorbs a lot more glucose. Could have implications in diabetes treatment. https://t.co/XsCsXaBuHm #EASD2022
-
-
Mashup Score: 0Media Centre | EASD - 2 year(s) ago
About usThe aims of the Association are to encourage and support research in the field of diabetes, the rapid diffusion of acquired knowledge and to facilitate its application. Cookies facilitate the provision of our services. By using our services you consent to the use of Cookies. More information about our Privacy Policy.
Source: www.easd.orgCategories: Endocrinology, Latest HeadlinesTweet-
Webcasts from #EASD2022 are now available for all!😀 👉 https://t.co/m1D5b2rrXS Our Media Centre contains 1000's of abstracts, #webcasts, audio and video #presentations from past EASD's Annual Meetings - explore this invaluable source of #diabetes #science and #research. https://t.co/WNtztvzvU0
-
-
Mashup Score: 0Tirzepatide's Benefits Expand: Lean Mass Up, Serum Lipids Down - 2 year(s) ago
New results from the SURMOUNT-1 trial of tirzepatide in people with obesity show further positive effects.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
New insights into the benefits of treatment with the "twincretin" tirzepatide for people with overweight or obesity – with or without diabetes – come from new findings reported at #EASD2022. https://t.co/9lvNeWj8qS
-
-
Mashup Score: 1
EASDtv hostess Vivienne Parry speaks to debate participants Bruce Wolffenbuttel and Apostolos Tsapas together with session chair Leszek Czupryniak.#easd2022 …
Source: YouTubeCategories: Endocrinology, Latest HeadlinesTweet-
#insulin free treatment of #t2d is... ...coming or ...nonsense? 🤔 See what arguments #EASD2022 discussants @bhrw and @atsapas bring up at EASD TV https://t.co/uNy5PvGq5H
-
-
Mashup Score: 0Liver Fat Lowered by Ezetimibe-Statin Combination - 2 year(s) ago
A significant 5.8% decrease in hepatic steatosis was seen after 24 weeks’ treatment with ezetimibe and rosuvastatin comparing baseline with end of treatment values.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
Ezetimibe given in combination with rosuvastatin has a beneficial effect on liver fat in people with NAFLD. #EASD2022 https://t.co/1heEekgvqJ
-
-
Mashup Score: 5Liver Fat Lowered by Ezetimibe-Statin Combination - 2 year(s) ago
A significant 5.8% decrease in hepatic steatosis was seen after 24 weeks’ treatment with ezetimibe and rosuvastatin comparing baseline with end of treatment values.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
Ezetimibe given in combination with rosuvastatin has a beneficial effect on liver fat in people with NAFLD. #EASD2022 https://t.co/SxscoYEjPa
-
-
Mashup Score: 1Improve Diagnosis of Type of Heart Failure Common in Diabetes - 2 year(s) ago
Heart failure with preserved ejection fraction is common in people with type 2 diabetes but is often hard to recognize. Treatments newly proven to be effective make diagnosis an imperative.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Clinicians must maintain a high index of suspicion for signs and symptoms of #HF in people with #T2D or obesity and to regularly assess them, starting with just a few simple questions. #EASD2022 #CardioTwitter https://t.co/pqV2piawvx
-
-
Mashup Score: 2'Patients Need a Champion' for Their Diabetes Care - 2 year(s) ago
How do you advocate for your patients? How do you make sure their care is equitable? Anne L. Peters, MD, discusses the importance of advocacy.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
📹 Dr Anne Peters is optimistic with a call to action for HCPs to be the champion, the advocate, for their patients with #diabetes. #EASD2022 #EndHealthcareDisparities https://t.co/FLqb5uTtLZ https://t.co/P3nZKUjfID
-
Prof. Maike Sander received the 16th Albert Renold Prize at #EASD2022 and #EASDTV talked to her about her research: https://t.co/GqmcVSftIe Who will follow @msanderlab as recipient of the 17th Albert Renold Prize at #EASD2023? Nominate your candidate: https://t.co/8Kuk2Mb75G https://t.co/HXqW0zkB6U